Submitted by Anonymous (not verified) on 30 November 2023 - 15:31
Human medicines European public assessment report (EPAR): Kalydeco, ivacaftor, Cystic Fibrosis, Date of authorisation: 23/07/2012, Revision: 38, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kalydeco, ivacaftor, Cystic Fibrosis, Date of authorisation: 23/07/2012, Revision: 38, Status: Authorised